{"id":"CHEMBL1171837","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12","inchiKey":"PHXJVRSECIGDHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PONATINIB","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iclusig"],"synonyms":["AP-24534","AP24534","Ponatinib"],"crossReferences":{"DailyMed":["ponatinib%20hydrochloride"],"PubChem":["137275996"],"Wikipedia":["Ponatinib"],"drugbank":["DB08901"],"chEBI":["78543"]},"childChemblIds":["CHEMBL2105708"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000220","EFO_0000571","Orphanet_44890","EFO_1000131","EFO_0000222","EFO_0008550","MONDO_0003541","EFO_0003060","EFO_0000311","EFO_0000565","EFO_0000339","EFO_0003841","EFO_0000702","MONDO_0015277","EFO_0000519"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL119443","canonicalSmiles":"C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"WVVSZNPYNCNODU-XTQGRXLLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGONOVINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ergobasine","Ergometrine","Ergostetrine","Ergotocine"],"crossReferences":{"PubChem":["124882895","144205575","26754288"],"Wikipedia":["Ergometrine"],"drugbank":["DB01253"],"chEBI":["4822"]},"childChemblIds":["CHEMBL1213135"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200437","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"XHKUDCCTVQUHJQ-LCYSNFERSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINIDINE GLUCONATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1294","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duraquin","Quinact","Quinaglute","Quinalan","Quinatime","Quinidine gluconate"],"synonyms":["Dura-tab","Gluconic acid quinidine salt","Gluquinate","NSC-757297","Quinidine gluconate","Quinidine mono-d-gluconate","Quinidine monogluconate, d-"],"crossReferences":{"DailyMed":["quinidine%20gluconate"],"chEBI":["27502"]},"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0001068","HP_0004308"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for malaria and ventricular arrhythmia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200907","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O","inchiKey":"KVJXBPDAXMEYOA-CXANFOAXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRILOSTANE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Modrastane","Modrenal"],"synonyms":["Desopan","NSC-758904","Trilostane","WIN 24,540","WIN-24540"],"crossReferences":{"PubChem":["144206007","144212723","170465836"],"Wikipedia":["Trilostane"],"drugbank":["DB01108"],"chEBI":["32260"]},"linkedTargets":{"rows":["ENSG00000203859"],"count":1},"linkedDiseases":{"rows":["EFO_0005539","EFO_0000673"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for adrenal gland disease and has 1 investigational indication."}
{"id":"CHEMBL1200971","canonicalSmiles":"CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1","inchiKey":"FUBBGQLTSCSAON-PBFPGSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOGLYCIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kafocin"],"synonyms":["39435","Cefaloglycin","Cefaloglycin dihydrate","Cephaloglycin","Cephaloglycin anhydrous","Cephaloglycin dihydrate","Kefocin"],"crossReferences":{"Wikipedia":["Cefaloglycin"],"drugbank":["DB00689"],"chEBI":["34613"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970."}
{"id":"CHEMBL1200980","canonicalSmiles":"C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O","inchiKey":"HZEQBCVBILBTEP-ZFINNJDLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTROPIPATE","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL494753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estropipate","Harmogen","Ogen","Ogen .625","Ogen 1.25","Ogen 2.5","Ogen 5","Ortho-est"],"synonyms":["Estrone sulfate piperazine salt","Estropipate","NSC-758912","Piperazine estrone sulfate","Piperazine estrone sulphate","Sulestrex piperazine"],"crossReferences":{"DailyMed":["estropipate"],"PubChem":["144206901","26750028","56463533"],"Wikipedia":["Estropipate"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0004266","EFO_1000096","EFO_0003882","EFO_0003922"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201124","canonicalSmiles":"NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O","inchiKey":"BWHLPLXXIDYSNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOROLAC TROMETHAMINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL469","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acular","Acular ls","Acular preservative free","Acuvail","Ketorolac tromethamine","Sprix","Toradol"],"synonyms":["Dolac","Ketorolac trometamol","Ketorolac tromethamine","Lixidol","NSC-758637","Tarasyn"],"crossReferences":{"DailyMed":["ketorolac%20tromethamine"],"PubChem":["124881877","26747544","49681816","50106489","8139924"],"chEBI":["6130"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0018373","MONDO_0003005","EFO_1001139","EFO_0003777","HP_0200026","EFO_1001178","HP_0000545","EFO_0008507","MONDO_0007254","HP_0003418","EFO_0003843","MONDO_0100431","MONDO_0005277","MP_0001845","EFO_1001412","HP_0030839","EFO_0004253","MONDO_0005129","HP_0003419","EFO_0005611","EFO_1000859","HP_0000540","MONDO_0002258","MONDO_0005178","EFO_1001250","MONDO_0005475"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201247","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O","inchiKey":"BLCLNMBMMGCOAS-URPVMXJPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GOSERELIN","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zoladex"],"synonyms":["Goserelin","Goserelin acetate","ICI 118,630","ICI-118630"],"crossReferences":{"DailyMed":["goserelin%20acetate"],"Wikipedia":["Goserelin"],"drugbank":["DB00014"]},"childChemblIds":["CHEMBL1200501"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000545","EFO_1001757","EFO_0001065","MONDO_0008170","MONDO_0007254","MONDO_0000521","EFO_0000313","MONDO_0002087","Orphanet_481","EFO_0000305","MONDO_0008315","EFO_0001663","EFO_0000195","EFO_0000304","MONDO_0002158","EFO_0000553","EFO_0006861","EFO_0000731","HP_0008209","EFO_0000673","EFO_0000196","EFO_0000183","MONDO_0024880","EFO_0003922"],"count":26},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 4 approved and 22 investigational indications."}
{"id":"CHEMBL1201341","canonicalSmiles":"CCOP(=O)(OCC)SCC[N+](C)(C)C","inchiKey":"BJOLKYGKSZKIGU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECHOTHIOPHATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Echothiophate","Echothiophate cation","Echothiophate ion","Ecothiopate","Ecothiopate cation"],"crossReferences":{"Wikipedia":["Echothiophate"],"drugbank":["DB01057"],"chEBI":["4753"]},"childChemblIds":["CHEMBL1200367"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["HP_0000545","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for glaucoma."}
{"id":"CHEMBL1201837","drugType":"Protein","blackBoxWarning":true,"name":"ECALLANTIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DX-88","Ecallantide","Escallantide"],"crossReferences":{"DailyMed":["ecallantide"],"DrugCentral":["4846"],"Wikipedia":["Ecallantide"]},"linkedTargets":{"rows":["ENSG00000164344"],"count":1},"linkedDiseases":{"rows":["EFO_0005532","Orphanet_91378"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for hereditary angioedema and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1231519","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1/C=C/Br","inchiKey":"LKWCVKAHHUJPQO-PIXDULNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231519","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232077","canonicalSmiles":"N[C@H](C(=O)O)c1ccc(O)cc1","inchiKey":"LJCWONGJFPCTTL-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXFENICINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(s)-(4-hydroxyphenyl)glycine","4-hydroxyphenylglycine, (s)-","L-2-(p-hydroxyphenyl)glycine","Oxfenicine","UK-25,842","UK-25842"],"crossReferences":{"PubChem":["144205697","170466530"],"drugbank":["DB04291"],"chEBI":["31755"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232653","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO[P@](=O)(O)O[P@@](=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)c2cc1C","inchiKey":"VWWQXMAJTJZDQX-UYBVJOGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVIN ADENIN DINUCLEOTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenine-riboflavin dinucleotide","Flavin adenin dinucleotide","Flavin adenine dinucleotide","Flavin-adenine dinucleotide","Flavine adenine dinucleotide","Flavine adenosine diphosphate","Flavine-adenine dinucleotide","NSC-112207"],"crossReferences":{"PubChem":["50112827"],"drugbank":["DB03147"],"chEBI":["16238"]},"childChemblIds":["CHEMBL2356834"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234081","name":"CHEMBL1234081","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04136"]}}
{"id":"CHEMBL125236","canonicalSmiles":"CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1","inchiKey":"YVXVTLGIDOACBJ-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL125236","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Andarine"],"drugbank":["DB07423"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255901","canonicalSmiles":"C/C=C1\\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2","inchiKey":"ZRJBHWIHUMBLCN-HZRLMBICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HUPERZINE A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-huperzine a","(-)-selagine","Huperzine a","L-huperzine a","Selagine"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL127643","canonicalSmiles":"CCCCc1cc2ccccc2c(OCCN(C)C)n1","inchiKey":"XNMYNYSCEJBRPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHISOQUIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-39695","Quinisocaine"],"crossReferences":{"PubChem":["11112524"],"Wikipedia":["Quinisocaine"],"drugbank":["DB13683"]},"childChemblIds":["CHEMBL1533364"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1276663","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccn4ncccc43)CS[C@H]12)c1nsc(N)n1","inchiKey":"QDUIJCOKQCCXQY-WHJQOFBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOZOPRAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefozopran","Cefozopran hydrochloride"],"crossReferences":{"Wikipedia":["Cefozopran"],"drugbank":["DB13667"],"chEBI":["3502"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1291","canonicalSmiles":"CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C","inchiKey":"BQIPXWYNLPYNHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIPRANOLOL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Opthalmic toxicity"],"year":1990},"tradeNames":["Glauline","Optipranolol"],"synonyms":["BM-01.004","BM-01004","BM01.004","D,l-metipranolol","Metipranolol","Optipranolol","VUAB-6453","VUAB6453","VUAB6453 (SPOFA)"],"crossReferences":{"PubChem":["144205272","29215465"],"Wikipedia":["Metipranolol"],"drugbank":["DB01214"],"chEBI":["6897"]},"childChemblIds":["CHEMBL1200947"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for glaucoma. It was withdrawn in United Kingdom  in 1990 due to Opthalmic toxicity."}
{"id":"CHEMBL130865","canonicalSmiles":"NC(C(=O)O)c1ccc(O)cc1","inchiKey":"LJCWONGJFPCTTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-26","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-26"],"crossReferences":{"drugbank":["DB02601"],"chEBI":["50418"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1514715","canonicalSmiles":"CCNCC.O=S(=O)(O)c1cc(O)ccc1O","inchiKey":"HBGOLJKPSFNJSD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMSYLATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1232131","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dicynene","Dicynene 1000","Dicynone"],"synonyms":["Diethylamine dobesilate","E 141","E-141","Etamsilate","Etamsylate","Ethamsylate","MD 141","MD-141"],"crossReferences":{"DrugCentral":["1075"],"PubChem":["11112957","144204303"],"drugbank":["DB13483"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL1520","canonicalSmiles":"CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12","inchiKey":"SECKRCOLJRRGGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARDENAFIL","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levitra"],"synonyms":["BAY-389456","BAY38-9456","Vardenafil","Vivanza"],"crossReferences":{"DailyMed":["vardenafil%20hydrochloride"],"Wikipedia":["Vardenafil"],"drugbank":["DB00862"],"chEBI":["46295"]},"childChemblIds":["CHEMBL2106480","CHEMBL1874590","CHEMBL1339"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["HP_0000360","EFO_0001361","EFO_0000765","MONDO_0005149","EFO_0002687","EFO_0004234","HP_0000802","Orphanet_586","EFO_1000781","EFO_0000284","EFO_1001145"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for erectile dysfunction and has 7 investigational indications."}
{"id":"CHEMBL153036","canonicalSmiles":"CNCC[C@@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"RTHCYVBBDHJXIQ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-FLUOXETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluoxetine"],"crossReferences":{"PubChem":["50111060"],"drugbank":["DB08472"],"chEBI":["86991"]},"childChemblIds":["CHEMBL1256757"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1541","canonicalSmiles":"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OCC(=O)O)c3csc(N)n3)[C@H]2SC1","inchiKey":"OKBVVJOGVLARMR-QSWIMTSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFIXIME","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefixime","Cefspan","Oroken","Suprax"],"synonyms":["Anhydrous cefixime","CL 284,635","CL-284635","Cefixime","Cefixime anhydrous","Cefixime hydrate","Cefixime trihydrate","Cephoral","Citropen","FK 027","FK-027","FR 17027","FR-17027"],"crossReferences":{"DailyMed":["cefixime"],"PubChem":["85148376"],"Wikipedia":["Cefixime"],"drugbank":["DB00671"],"chEBI":["472657"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 9 approved and 5 investigational indications."}
{"id":"CHEMBL15594","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O","inchiKey":"YZXBAPSDXZZRGB-DOFZRALJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARACHIDONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arachidonate","Arachidonic acid","Cis-5,8,11,14-Eicosatetraenoic Acid"],"crossReferences":{"PubChem":["26747902","26753719","57261284"],"Wikipedia":["Arachidonic_acid"],"drugbank":["DB04557"],"chEBI":["15843"]},"childChemblIds":["CHEMBL3274190"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL156987","canonicalSmiles":"O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1","inchiKey":"ONVZFCHLOZUXRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-409513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-409513"],"crossReferences":{"PubChem":["124349840"],"drugbank":["DB01793"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1620794","canonicalSmiles":"CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC1CCCO1","inchiKey":"KBAFPSLPKGSANY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFRONYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Drosunal","Dubimax","Gevatran","Naftidrofuryl"],"crossReferences":{"drugbank":["DB13588"]},"childChemblIds":["CHEMBL1439099"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1626570","canonicalSmiles":"COS(=O)(=O)[O-].C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1","inchiKey":"NSILVESQCSUIAJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOCYCLIUM METHYLSULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201325","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tral"],"synonyms":["Hexocyclium methyl sulfate","Hexocyclium methylsulfate","Hexocyclium methylsulphate","Hexocyclium metilsulfate","Hexocyclium metilsulphate","NSC-30256"],"crossReferences":{"PubChem":["144206775"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1651905","canonicalSmiles":"O=C(COCCOCCOCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"JXMIBUGMYLQZGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOTROXIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acidum iotroxicum","Biliscopin","Iotroxic acid","SH 213 AB","SH-213 AB","SH-213AB"],"crossReferences":{"PubChem":["144206809"],"drugbank":["DB08945"]},"childChemblIds":["CHEMBL4297078"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742439","canonicalSmiles":"CN(C)CCn1nc(Cc2ccccc2)c2ccccc2c1=O","inchiKey":"LCAAMXMULMCKLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALASTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talastine"],"crossReferences":{"drugbank":["DB13349"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743259","canonicalSmiles":"CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CC","inchiKey":"IZBNNCFOBMGTQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOPERIDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etoperidone"],"crossReferences":{"drugbank":["DB09194"]},"childChemblIds":["CHEMBL3085482","CHEMBL4748719"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1908318","canonicalSmiles":"CC(=O)N[C@H]1[C@H](NC(=O)C[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CNC(=O)C[C@H](NC2=O)C(=O)N[C@@H](Cc2c[nH]c4ccccc24)C(=O)N[C@@H](Cc2ccccc2)C(=O)N3)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"NGCNKEZHGRXHNL-WVWQGFTISA-N","drugType":"Protein","blackBoxWarning":false,"name":"NEPADUTANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nepadutant"],"crossReferences":{"drugbank":["DB12538"]},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1908319","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C","inchiKey":"GVDMJXQHPUYPHP-FYQPLNBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORGESTRIENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-101105","Norgestrienone"],"crossReferences":{"drugbank":["DB13563"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1909079","drugType":"Small molecule","blackBoxWarning":false,"name":"STANNOUS FLUORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omnigel","Stop"],"synonyms":["Stannous fluoride","Tin fluoride (snf2)"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL193156","canonicalSmiles":"c1ccc2c(CCc3ccncc3)c[nH]c2c1","inchiKey":"UUEYCHLWAOBOHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL193156","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01953"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL204459","canonicalSmiles":"N[C@H](C(=O)N1CC(c2cc(F)ccc2F)=C[C@H]1c1ccccc1)C1CC1","inchiKey":"VCOUEHUEFUDZIS-PMACEKPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL204459","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08244"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL205786","canonicalSmiles":"Cc1ccc2c(c1C)CN(C(=O)N(C)C)C[C@@H]2c1cccc(O)c1","inchiKey":"HPVCRUIDFODATB-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL205786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07064"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2064455","canonicalSmiles":"Nc1ccn([C@@H]2C(F)=C(CO)[C@@H](O)[C@H]2O)c(=O)n1","inchiKey":"QLLGKCJUPWYJON-HLTSFMKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RODUCITABINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluorocyclopentenylcytosine","RX-3117","Roducitabine","Rx-3117","TV-1360"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2068839","canonicalSmiles":"Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1","inchiKey":"RECBFDWSXWAXHY-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RISLENEMDAZ","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CERC-301","Cerc-301","MK-0657","MK-0657, (-)-","Rislenemdaz","Rislenemdaz, (-)-"],"crossReferences":{"drugbank":["DB12063"]},"childChemblIds":["CHEMBL2036513"],"linkedTargets":{"rows":["ENSG00000273079","ENSG00000176884"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103740","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOXETATE DISODIUM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2221312","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eovist"],"synonyms":["Gadoxetate disodium","Gadoxetate sodium","Gadoxetic acid disodium","Gadoxetic acid sodium salt","Gadoxetic acid, disodium","SHL-569B","Sodium gadoxetate","ZK 139834","ZK-139834"],"crossReferences":{"DailyMed":["gadoxetate%20disodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008 and is indicated for liver disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103836","canonicalSmiles":"CCC[C@@H](C)C[C@H](N)CC(=O)O","inchiKey":"JXEHXYFSIOYTAH-SFYZADRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMAGABALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imagabalin","PD 0332334","PD-0332334","PF-00195889"],"crossReferences":{"drugbank":["DB12105"]},"childChemblIds":["CHEMBL2105673"],"linkedTargets":{"rows":["ENSG00000075461","ENSG00000157388","ENSG00000142408","ENSG00000165995","ENSG00000100346","ENSG00000157445","ENSG00000151067","ENSG00000166862","ENSG00000148408","ENSG00000198216","ENSG00000105605","ENSG00000167535","ENSG00000006116","ENSG00000007402","ENSG00000081248","ENSG00000102001","ENSG00000151062","ENSG00000108878","ENSG00000130433","ENSG00000141837","ENSG00000075429","ENSG00000006283","ENSG00000182389","ENSG00000196557","ENSG00000153956","ENSG00000067191"],"count":26},"linkedDiseases":{"rows":["HP_0000083","EFO_1001892","EFO_0005230"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104595","canonicalSmiles":"OC(CO/N=C(\\Cl)c1cccnc1)CN1CCCCC1","inchiKey":"NMOVJBAGBXIKCG-VKAVYKQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMOCLOMOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-822","BRLP-42","Bimoclomol"],"crossReferences":{"drugbank":["DB06258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105617","canonicalSmiles":"CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O","inchiKey":"CJDRUOGAGYHKKD-FUIWMBJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AJMALINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(17r,21r)-ajmalan-17,21-diol","Ajmalan-17,21-diol","Ajmaline","NSC-15627","Rauwolfine"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105733","canonicalSmiles":"CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1.O=P(O)(O)O","inchiKey":"FCCGJTKEKXUBFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUCAPARIB PHOSPHATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1173055","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-014699","AG-14699","AG014699","Ag 014699","PF-01367338","PF01367338","Rucaparib phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107691","canonicalSmiles":"COC(CN1CCN(CCC(O)c2ccccc2)CC1)c1ccccc1","inchiKey":"QSRHLIUOSXVKTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPROZINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eprozinol"],"crossReferences":{"drugbank":["DB13395"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107784","canonicalSmiles":"COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C","inchiKey":"ONDYALNGTUAJDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASQUINIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tasquinimod"],"crossReferences":{"Wikipedia":["Tasquinimod"],"drugbank":["DB05861"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107997","drugType":"Unknown","blackBoxWarning":false,"name":"SIZOFIRAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mc-glucan","Schizophyllan","Schizophyllane","Sixofilan","Sizofiran","Sonifilan"],"crossReferences":{"DrugCentral":["4048"]},"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108312","drugType":"Protein","blackBoxWarning":false,"name":"OZARELIX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-63153","D63153","Ozarelix"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000284","MONDO_0008315","HP_0011277"],"count":3},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108675","drugType":"Antibody","blackBoxWarning":false,"name":"DUPILUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dupixent","Regn668, sar231893"],"synonyms":["Dupilumab","REGN-668","REGN668","SAR-231893","SAR231893"],"crossReferences":{"DailyMed":["dupilumab"]},"linkedTargets":{"rows":["ENSG00000077238"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_1000668","EFO_0007486","EFO_0007425","MONDO_0019269","EFO_0010638","MONDO_0005271","EFO_0000274","Orphanet_634","EFO_0005531","HP_0100582","EFO_0004212","EFO_1001361","EFO_1001881","EFO_0005854","HP_0000964","EFO_0007140","EFO_0005532","EFO_1002029","HP_0012042","MONDO_0008315","EFO_0003060","EFO_0007187","EFO_0004232","MONDO_0100096","EFO_0000684","EFO_1000391","EFO_1000740","EFO_0004192","MONDO_0002406","MONDO_0004979","EFO_0000341","EFO_0007141"],"count":33},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved and 20 investigational indications."}
{"id":"CHEMBL2108806","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"BEMIPARIN SODIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zibor"],"synonyms":["Badyket","Bemiparin sodium","Hibor","Zivor"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","MONDO_0100096","EFO_0003907"],"count":3},"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109070","drugType":"Unknown","blackBoxWarning":false,"name":"LACTOBACILLUS ACIDOPHILUS","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gynatren"],"synonyms":["Acidophilus","Bacillus acidophilus whole","Bacterium acidophilum whole","Lacteol","Lactobacillus acidophilus","Lactobacillus acidophilus whole","Lactobacterium acidophilum whole","Lactomin"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL2109306","drugType":"Antibody","blackBoxWarning":false,"name":"LMB-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-1"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109382","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-639","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-639"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110760","canonicalSmiles":"CCN(CCO)CCn1c(Cc2ccccc2)nc2c1c(=O)n(C)c(=O)n2C","inchiKey":"VVUYEFBRTFASAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMIFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamifylline"],"crossReferences":{"drugbank":["DB13203"]},"childChemblIds":["CHEMBL2105899"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110849","canonicalSmiles":"CC(C)N(CCC(c1ccccc1)c1ccccc1)C(C)C","inchiKey":"YBJKOPHEJOMRMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIISOPROMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diisopromine","Disopromine","R-253"],"crossReferences":{"drugbank":["DB13476"]},"childChemblIds":["CHEMBL2106314"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL214205","canonicalSmiles":"NCCN1CCOCC1","inchiKey":"RWIVICVCHVMHMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Morpholinoethanamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Morpholinoethanamine"],"crossReferences":{"PubChem":["144212388"],"drugbank":["DB03096"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL214268","canonicalSmiles":"O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1","inchiKey":"IPKZCLGGYKRDES-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHA-543613","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.179.420J","PHA-543,613","PHA-543613","Pha-00543613","Pha-543613"],"crossReferences":{"PubChem":["144210766"],"Wikipedia":["PHA-543,613"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219415","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOTERATE MEGLUMINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dotarem"],"synonyms":["Gadolinium-dota meglumine","Gadoterate meglumine","Gd-dota meglumine","Magnescope","Meglumine gadoterate","P 449","P-449","P449"],"crossReferences":{"DailyMed":["gadoterate%20meglumine"],"DrugCentral":["1267"],"chEBI":["73727"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2221312","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOXETIC ACID","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gadoxetate","Gadoxetic acid"],"crossReferences":{"DailyMed":["gadoxetate%20disodium"],"DrugCentral":["3259","4646"]},"childChemblIds":["CHEMBL2103740"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008 and is indicated for liver disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL22498","canonicalSmiles":"CC(Cc1ccccc1)NN","inchiKey":"VXTWEDPZMSVFEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENIPRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pheniprazine","Pheniprazine dl-form"],"crossReferences":{"Wikipedia":["Pheniprazine"],"drugbank":["DB09250"]},"childChemblIds":["CHEMBL2106542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2356097","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)CCC(=O)O","inchiKey":"RGHAZVBIOOEVQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOPROLOL SUCCINATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kapspargo sprinkle","Metoprolol succinate","Toprol","Toprol Xl","Toprol-xl"],"synonyms":["H 93/26 SUCCINATE","Metoprolol hemisuccinate","Metoprolol succinate","Seloken-zok","Selozok"],"crossReferences":{"DailyMed":["metoprolol%20succinate"],"PubChem":["144206706"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0005251","EFO_0000275","EFO_0000373","EFO_0000266","EFO_0000538","EFO_0009094","EFO_0000537","EFO_0003913","Orphanet_98896","EFO_0008585","Orphanet_79292","MONDO_0001134","EFO_0003144","EFO_0008583","EFO_0000341","EFO_0008586","HP_0001653"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL237600","canonicalSmiles":"C=CC(=O)c1ccc(CCCCCC)cc1","inchiKey":"IINHTEWASPUCMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237600","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217563","90341136"],"drugbank":["DB08085"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL249420","canonicalSmiles":"CCCN[C@@H]1CCc2nc(N)sc2C1","inchiKey":"FASDKYOPVNHBLU-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPRAMIPEXOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r)-pramipexole","Dexpramipexole"],"crossReferences":{"drugbank":["DB15130"]},"childChemblIds":["CHEMBL2105687","CHEMBL3216394"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL26215","canonicalSmiles":"CCCCCCCCO","inchiKey":"KBPLFHHGFOOTCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTANOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Octanol","Octan-1-ol","Octanol"],"crossReferences":{"PubChem":["144208571","144210416","17389591","26752869","26752870","49732778"],"Wikipedia":["Octanol"],"drugbank":["DB12452"],"chEBI":["16188"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL268291","canonicalSmiles":"CN(C)C=O","inchiKey":"ZMXDDKWLCZADIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLFORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208457","17388882","17389908","26752801"],"Wikipedia":["Dimethylformamide"],"drugbank":["DB01844"],"chEBI":["17741"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268501","canonicalSmiles":"Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1","inchiKey":"JTIGKVIOEQASGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROQUAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arthrex"],"synonyms":["43-715","Proquazone"],"crossReferences":{"Wikipedia":["Proquazone"],"drugbank":["DB13649"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL29024","canonicalSmiles":"CC(C)(C)c1snc(O)c1C[C@H](N)C(=O)O","inchiKey":"FHWOAQCPEFTDOQ-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL29024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL297453","canonicalSmiles":"O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1","inchiKey":"WMBWREPUVVBILR-WIYYLYMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPIGALOCATECHIN GALLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Epigallocatechin Gallate","Epigalocatechin gallate"],"crossReferences":{"PubChem":["144208666","144213767","26719730","26757738","49681655"],"Wikipedia":["Epigallocatechin_gallate"],"drugbank":["DB12116"],"chEBI":["4806"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 39 investigational indications."}
{"id":"CHEMBL3085474","canonicalSmiles":"N=C(N)c1ccc(-c2ccc(OC[C@@H]3C[C@@H](CC(=O)O)C(=O)N3)cc2)cc1","inchiKey":"IKZACQMAVUIGPY-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRADAFIBAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fradafiban"],"crossReferences":{"drugbank":["DB06472"],"chEBI":["73266"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL310671","canonicalSmiles":"O=C1NS(=O)(=O)c2ccccc21","inchiKey":"CVHZOJJKTDOEJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SACCHARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sweeta"],"synonyms":["Benzosulfinide","E-954(I)","E954","Gluside","INS NO.954(I)","INS-954(I)","NSC-5349","Saccharin","Saccharinum"],"crossReferences":{"PubChem":["144204911","144209078","144213267","170465766","26748529","26753733"],"Wikipedia":["Saccharin"],"drugbank":["DB12418"],"chEBI":["32111"]},"childChemblIds":["CHEMBL2447917"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL315795","canonicalSmiles":"Cc1ncsc1CCCl","inchiKey":"PCLITLDOTJTVDJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMETHIAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Heminevrin"],"synonyms":["Chlormethiazole","Clomethiazole","Distraneurine","SCTZ [AS EDISYLATE]"],"crossReferences":{"PubChem":["11113756","144204482","170466516","26751938","90341262"],"Wikipedia":["Clomethiazole"],"drugbank":["DB06470"]},"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0005230"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL319144","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cnc2ccccn12)P(=O)(O)O","inchiKey":"VMMKGHQPQIEGSQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINODRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minodronate","Minodronic acid","NSC-725590","ONO-5920","YM 529","YM-529"],"crossReferences":{"PubChem":["144206806"],"Wikipedia":["Minodronic_acid"],"drugbank":["DB06548"]},"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0003854","EFO_0003882"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL321691","canonicalSmiles":"CCSC(=N)N","inchiKey":"VFIZBHJTOHUOEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLISOTHIOUREA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Ethyl-Isothiourea"],"crossReferences":{"PubChem":["11111141","11113749","50104607","90341019"],"drugbank":["DB02234"]},"childChemblIds":["CHEMBL4531203","CHEMBL1255945"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545231","canonicalSmiles":"c1ccc(-c2nnc(O[C@@H]3C4CC5C[C@H]3CN(C5)C4)s2)cc1","inchiKey":"QZDCYUCETTWCMO-CDFKWJNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-126","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-126","Abt-126","Nelonicline"],"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545345","drugType":"Small molecule","blackBoxWarning":false,"name":"UR-63325","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seliforant","UR-63325","Ur-63325"],"linkedTargets":{"rows":["ENSG00000134489"],"count":1},"linkedDiseases":{"rows":["EFO_0003956"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545411","drugType":"Small molecule","blackBoxWarning":false,"name":"MF101","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mf101"],"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["HP_0031217","EFO_0003922"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545419","drugType":"Antibody","blackBoxWarning":false,"name":"TELISOTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-700","Abt-700","Telisotuzumab"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL363559","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"NHVNXKFIZYSCEB-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYTHYMIDINE_TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["dTTP"],"crossReferences":{"Wikipedia":["Thymidine_triphosphate"],"drugbank":["DB02452"],"chEBI":["18077"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36715","canonicalSmiles":"NC(=O)CN1CCCC1=O","inchiKey":"GMZVRMREEHBGGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRACETAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabacet","Nootrop","Nootrop 1200","Nootrop 400","Nootrop 800","Nootropil"],"synonyms":["CL-871","Myocalm","NSC-758191","Piracetam"],"crossReferences":{"PubChem":["11111637","11111638","11532905","144203780","144212307","170465901","26747624","26747625","50106825","50106826","85231187","90341798"],"Wikipedia":["Piracetam"],"drugbank":["DB09210"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for attention deficit hyperactivity disorder and has 7 investigational indications."}
{"id":"CHEMBL3707349","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(-c4csc(-c5ccccc5)n4)cc32)c1C","inchiKey":"QDWKGEFGLQMDAM-ULJHMMPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMCASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amcasertib","BBI-503","BBI503"],"crossReferences":{"drugbank":["DB14866"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL374107","canonicalSmiles":"Nc1nc(O)c2[nH]nnc2n1","inchiKey":"LPXQRXLUHJKZIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-AZAGUANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Azaguanine"],"crossReferences":{"PubChem":["11112293","124899167","47193666","538242"],"Wikipedia":["8-Azaguanine"],"drugbank":["DB01667"],"chEBI":["63486"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989738","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O","inchiKey":"ZBJNZFQKYZCUJU-PAHFEQBRSA-N","drugType":"Protein","blackBoxWarning":true,"name":"POLYMYXIN B","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Polymixin b","Polymyxin b"],"crossReferences":{"DailyMed":["polymyxin%20b%20sulfate"]},"childChemblIds":["CHEMBL3989714"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 5 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989862","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"SVCSMAZYWOQCBW-NVJMFHFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEFCALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-5181","M-518101","M5181","M518101","Pefcalcitol"],"crossReferences":{"drugbank":["DB11786"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL407632","canonicalSmiles":"CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1","inchiKey":"PVRYEWOXWGDQHA-URLMMPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NUTLIN-2","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nutlin-2"],"crossReferences":{"drugbank":["DB02872"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4206033","canonicalSmiles":"C[C@H]1C[C@@H](n2c(Nc3ccc(OC(F)(F)F)cc3)nc3cc(CCC(=O)O)ccc32)CC(C)(C)C1","inchiKey":"RNMAUIMMNAHKQR-QFBILLFUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY1436032","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bay1436032"],"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297279","canonicalSmiles":"NC(=O)CC[C@@H](C(=O)O)N(CCNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)C(=O)c1ccc(NCc2cnc3nc(N)[nH]c(=O)c3n2)cc1","inchiKey":"ZMTAPBHUSYTHBY-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EC-17","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ec 17","Ec-17","Ec17 (folate-fitc)","Folate-fitc","Folate-fluorescein conjugate"],"crossReferences":{"drugbank":["DB12559"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297355","canonicalSmiles":"C[C@@H](C1CC1)N1Cc2cc(-c3cc(C(=O)N(C)C)no3)cc(Cl)c2C1=O","inchiKey":"MCPBSUCAISQZQK-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-8418","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD8418","Azd 8418","Azd-8418","Azd8418"],"crossReferences":{"drugbank":["DB13102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297703","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-962476","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-962476"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297881","drugType":"Unknown","blackBoxWarning":false,"name":"AMG-427","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 427","AMG-427","Amg 427","Amg-427"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297907","drugType":"Antibody","blackBoxWarning":false,"name":"TETULOMAB TETRAXETAN LU-177","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(sup 177)lu-tetulomab","177lu-tetraxetan-tetulomab","177lu-tetulomab","Betalutin","Tetulomab tetraxetan lu-177"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4300049","canonicalSmiles":"CCOCCCCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1C","inchiKey":"BBIRATBJZBAXFS-ZOBORPQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UT-231B","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297332"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4303323","canonicalSmiles":"C[C@H](Nc1ncnc2[nH]cnc12)c1nc2ccc(F)cc2c(=O)n1-c1ccccc1","inchiKey":"DOCINCLJNAXZQF-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acalisib","CAL-120","CAL120","GS-9820","GS9820","Gs-9820"],"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0001642"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4303449","canonicalSmiles":"C#CC[C@H](c1nc2cc(Cl)ccc2c(=O)n1Nc1ccccc1)N(CCCN)C(=O)c1cccc(Cl)c1F","inchiKey":"UPJSUQWHUVLLNW-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARQ-621","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arq 621","Arq-621"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL432481","canonicalSmiles":"C[C@]1(C(=O)O)CSC(c2ccc(O)cc2O)=N1","inchiKey":"OEUUFNIKLCFNLN-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFERITRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deferitrin","GT-56-252","GT56-252"],"childChemblIds":["CHEMBL523672"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL445813","canonicalSmiles":"O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl","inchiKey":"OVPNQJVDAFNBDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-7519","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT 7519","AT-7519","AT7519","At-7519","Cdki at7519"],"crossReferences":{"PubChem":["137275934","137275935"],"drugbank":["DB08142"]},"childChemblIds":["CHEMBL497478"],"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000123374","ENSG00000134058","ENSG00000164885","ENSG00000135446","ENSG00000155111","ENSG00000105810","ENSG00000167258","ENSG00000136807","ENSG00000059758","ENSG00000138395","ENSG00000058091","ENSG00000248333","ENSG00000132964","ENSG00000117266","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","EFO_0000574","EFO_0001378","EFO_1001469"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4468815","canonicalSmiles":"Cc1ccc2nc(N3CCS(=O)(=O)c4ccccc4C3)nc(NCC3(N)COC3)c2c1","inchiKey":"GAAICKUTDBZCMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIRESOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-0529","AK0529","Ak0529","RO-0529","Ziresovir"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL453","canonicalSmiles":"Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C","inchiKey":"NHUHCSRWZMLRLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOXAZOLE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entusil","Gantrisin","Neazolin","Sosol","Soxazole","Sulfafurazole","Sulfalar","Sulfisoxazole","Sulphafurazole","Sulsoxin"],"synonyms":["Eryzole","NSC-13120","NSC-683536","Pediazole","Sulfafurazole","Sulfisoxazole","Sulphafurazole"],"crossReferences":{"PubChem":["11112277","11113344","124882166","144203960","144206511","144209463","144213168","170464636","17389726","26751527","859862"],"Wikipedia":["Sulfafurazole"],"drugbank":["DB00263"],"chEBI":["102484"]},"childChemblIds":["CHEMBL1200321"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for bacterial disease and eye infection and has 1 investigational indication."}
{"id":"CHEMBL455","canonicalSmiles":"CC(=O)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"SKIVFJLNDNKQPD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACETAMIDE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Klaron"],"synonyms":["Bleph-10","Bleph-30","Cetamide","FML-S","Klaron","NSC-63871","Ocusulf-10","Ocusulf-30","SULF-10","SULF-15","Sulfacel-15","Sulfacetamide","Sulfacetamide (triple sulfa)","Sulfacetamidum","Sulfair-15","Sulphacetamide","Sulster","Sulten-10","Triple sulfa (sulfacetamide)","Urosulfon"],"crossReferences":{"DailyMed":["sulfacetamide%20sodium"],"PubChem":["144204397","144209197","144213417","170464944","17388721","56422206","855639"],"Wikipedia":["Sulfacetamide"],"drugbank":["DB00634"],"chEBI":["63845"]},"childChemblIds":["CHEMBL1200416","CHEMBL1723241"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1945 and has 5 approved and 1 investigational indication."}
{"id":"CHEMBL455706","canonicalSmiles":"C[C@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@H]12","inchiKey":"IVFYLRMMHVYGJH-PVPPCFLZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALUSTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calusterone","Dimethyltestosterone","Methosarb","NSC-88536","U-22,550","U-22550"],"crossReferences":{"drugbank":["DB01564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594275","canonicalSmiles":"N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1","inchiKey":"NLFLXLJXEIUQDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUSACITINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASN-002","ASN002","Asn-002","Asn002","EN-3351","EN3351","Gusacitinib"],"childChemblIds":["CHEMBL4594276"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000165025","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":5},"linkedDiseases":{"rows":["EFO_0000403","MONDO_0002406","MONDO_0018906","EFO_0000274","EFO_1001469"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4594403","canonicalSmiles":"CC1=CN2CCS(=O)(=O)N=C2C(c2ccc(OC3CCCCC3)cc2)=N1","inchiKey":"PXJBHEHFVQVDDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-653","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-653"],"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594604","drugType":"Antibody","blackBoxWarning":false,"name":"RIPERTAMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ripertamab","SCT-400","SCT400","Sct400"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL46257","canonicalSmiles":"NCCCCN","inchiKey":"KIDHWZJUCRJVML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUTRESCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-60545","Putrescine"],"crossReferences":{"PubChem":["11111663","90341517"],"Wikipedia":["Putrescine"],"drugbank":["DB01917"],"chEBI":["17148"]},"childChemblIds":["CHEMBL1528028","CHEMBL1255652","CHEMBL3229239"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL462712","canonicalSmiles":"CN1CCN(c2cnc3cc(C(F)(F)F)cc(-c4cccc(O)c4)c3n2)CC1","inchiKey":"QNCYYRHIUFGGJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL462712","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650358","canonicalSmiles":"CCCc1c(-c2ccccc2)nn(-c2ccccn2)c1O.Cl","inchiKey":"GMFJXGGAGPCRBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISUZINAXIB HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4650894","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APX-115","Apx-115","EWHA-18278","Isuzinaxib hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650400","drugType":"Unknown","blackBoxWarning":false,"name":"INCOMPLETE FREUND'S ADJUVANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Freund's adjuvant incomplete","Incomplete freund's adjuvant","Montanide isa 51","Montanide isa 51 vg"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL4650498","drugType":"Antibody","blackBoxWarning":false,"name":"LUSVERTIKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lusvertikimab","OSE-127","Ose-127"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650733","canonicalSmiles":"N=C(NC(=N)N1CCCC1)Nc1ccc(OC(F)(F)F)cc1","inchiKey":"NGFUHJWVBKTNOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IM-156 FREE BASE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HL271"],"childChemblIds":["CHEMBL4650309"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL478524","canonicalSmiles":"Cc1ccc(-n2cc(CNCC3CCCCC3)c3ccccc32)cc1","inchiKey":"MMIJMYOYKAKQPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478524","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479880","canonicalSmiles":"CCCCNS(=O)(=O)c1ccccc1","inchiKey":"IPRJXAGUEGOFGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Butylbenzenesulfonamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Butylbenzenesulfonamide"],"crossReferences":{"PubChem":["144208890","144213501"],"drugbank":["DB02055"],"chEBI":["44237"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48109","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(Nc3ccc(C(F)(F)F)cc3)n2)s1","inchiKey":"MEZFDQUDLQCVNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02915"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48608","canonicalSmiles":"Cc1cc(Br)c(O)c(-c2cc3cc(C(=N)N)ccc3[nH]2)c1","inchiKey":"BVTBOJXEAPSOEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48608","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04215"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL487431","canonicalSmiles":"Cc1ccc(C(=O)NCCC2CCCC2)cc1C(=O)Nc1ccc(N)nc1","inchiKey":"CLEGTVIMOPPIBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL487431","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07537"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL515387","canonicalSmiles":"O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1","inchiKey":"QWEWGXUTRTXFRF-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOSOGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gosogliptin","PF-00734200","PF-734,200","PF-734200"],"crossReferences":{"drugbank":["DB08382"]},"childChemblIds":["CHEMBL3526419"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL563251","canonicalSmiles":"CN1C[C@H]2[C@@H](C1)[C@@H]2CN(Cc1ccc(F)c(Cl)c1)C(=O)c1cn(C)cn1","inchiKey":"KYLOBHXXQOZRKK-FICVDOATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03463275","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03463275","Pf-3463275"],"crossReferences":{"drugbank":["DB11993"]},"linkedTargets":{"rows":["ENSG00000196517"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL568","canonicalSmiles":"O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O","inchiKey":"ADIMAYPTOBDMTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXAZEPAM","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lederpam","Oxazepam","Serax","Serenid fte","Zaxopam"],"synonyms":["J3.308A","NSC-169448","Oxazepam","Oxazepam civ","Oxozepam","Temazepam impurity, oxazepam-","WY-3498"],"crossReferences":{"DailyMed":["oxazepam"],"PubChem":["144205125","144206372","144207898","144213809","29215230"],"Wikipedia":["Oxazepam"],"drugbank":["DB00842"],"chEBI":["7823"]},"childChemblIds":["CHEMBL3251468"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000163285","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0004777","MONDO_0002050","EFO_0006788","HP_0000726","EFO_0000764","EFO_0003768","MONDO_0007079","EFO_0010445","EFO_0005230","HP_0000713"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL577","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"LZFZMUMEGBBDTC-QEJZJMRPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENALAPRILAT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vasotec"],"synonyms":["Enalaprilat","MK-421","MK-422"],"crossReferences":{"DailyMed":["enalaprilat"],"Wikipedia":["Enalaprilat"],"drugbank":["DB09477"],"chEBI":["4786"]},"childChemblIds":["CHEMBL3989406"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000407","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL593442","canonicalSmiles":"Cc1ccnc2c1ccc1c(C)ccnc12","inchiKey":"JIVLDFFWTQYGSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL593442","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02586"]},"childChemblIds":["CHEMBL1338667"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL594972","canonicalSmiles":"OC[C@H]1O[C@@]2(CC(c3ccccc3)=NO2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"YLTDNVVQKRHCJP-RKQHYHRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL594972","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08151"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL608806","canonicalSmiles":"CCOC(=O)[C@@H]1C2CCC(C[C@@H]1OC(=O)c1ccccc1)N2C","inchiKey":"NMPOSNRHZIWLLL-SSHXOBKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COCAETHYLENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cocaethylene","ETHYLCOCAINE","Ethylbenzoylecgonine","Homocaine","Homococaine","J21.586D","O-benzoyl-l-ecgonine ethyl ester"],"crossReferences":{"Wikipedia":["Cocaethylene"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL61006","canonicalSmiles":"CC(N)C(O)c1ccccc1","inchiKey":"DLNKOYKMWOXYQA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPROPANOLAMINE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"],"year":2002},"tradeNames":[],"synonyms":["Fansia","NSC-9920","Norephedrine","Phenylfenesin","Phenylpropanolamine","Propadrine","Rinexin"],"childChemblIds":["CHEMBL1200695","CHEMBL2146104","CHEMBL1201535"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000120907"],"count":2},"linkedDiseases":{"rows":["MONDO_0004979","HP_0001742"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958 and is indicated for nasal congestion. It was withdrawn in United States  in 2002 due to Neurotoxicity."}
{"id":"CHEMBL62136","canonicalSmiles":"O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1","inchiKey":"SGIWFELWJPNFDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T091317","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T0901317"],"crossReferences":{"PubChem":["124892235","26754513","29215533","85257301","99495594"],"drugbank":["DB07080"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62897","canonicalSmiles":"Cc1cc(I)c(O)c(C(=O)Nc2ccc(C(=N)N)c(Cl)c2)c1","inchiKey":"QKGFTDAISIBIBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62897","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06857"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL67133","canonicalSmiles":"C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nsc2c1","inchiKey":"UCIDPJLYUKNYFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL67133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02544"]},"childChemblIds":["CHEMBL112210"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83547","canonicalSmiles":"Cc1ccc(Sc2cccc3nc(N)nc(N)c23)cc1","inchiKey":"UOJFGEAPSYQDIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL83547","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04306"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL858","canonicalSmiles":"O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O","inchiKey":"KCXVZYZYPLLWCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Versene acid"],"synonyms":["Edetate","Edetic Acid","Edetic acid","Edta","Ethylenebis(iminodiacetic acid)"],"crossReferences":{"PubChem":["144209934","26754509","29215444"],"Wikipedia":["Ethylenediaminetetraacetic_acid"],"drugbank":["DB00974"],"chEBI":["42191"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL86954","canonicalSmiles":"NCC(N)=O","inchiKey":"BEBCJVAWIBVWNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOMETHYLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Amino-Acetamide"],"crossReferences":{"drugbank":["DB03636"],"chEBI":["42843"]},"childChemblIds":["CHEMBL1222057"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL8943","canonicalSmiles":"O=C(C[C@@H](Cc1cccc(O)c1)C(=O)N[C@H]1c2ccccc2C[C@H]1O)NO","inchiKey":"VXDKQRWTOJFQKH-BJZITVGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL8943","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
